Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012779 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of a Health Education Program in a Primary Care Setting
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 288
- Enrollment target
NCT00012779: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00012779 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 288 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (117% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012779, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 288 participants
- Enrollment target
Study Summary
This study was designed to assess the effectiveness of a Health Education Program (HEP) for improving the well-being and reducing the health care use and cost of care of frail older outpatient veterans, and for improving the well-being of their spouse caregivers. HEP is a multi-component group program delivered in 8 weekly, 2-hour sessions, and 10 monthly 2-hour follow-up sessions, it includes emotion-focused and problem focused coping strategies, education and support.
Interventions
- BEHAVIORAL Health Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Est. Completion | 2003-03 |
| Phase | Phase 2 |
What the finished NCT00012779 record still lists
NCT00012779 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (117% higher).
The record links to 0 conditions, and to 1 intervention - of which Health Education Program is the first listed.
NCT00012779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012779 about?
NCT00012779 is a clinical study titled "Effectiveness of a Health Education Program in a Primary Care Setting". This study was designed to assess the effectiveness of a Health Education Program (HEP) for improving the well-being and reducing the health care use and cost of care of frail older outpatient veterans, and for improving the well-being of their spouse caregivers. HEP is a multi-component group progr...
What is the current status of trial NCT00012779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 288 participants. Estimated completion is 2003-03.
What interventions are being tested in trial NCT00012779?
The interventions under investigation include: Health Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00012779?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00012779's enrollment target sits among peer trials
288 191st of 2000 higher than 1,810 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers